Publication Name	World Journal of Gastroenterology
Manuscript ID	33335
Country	South Korea

Received	2017-02-07 10:06
Peer-Review Started	2017-02-09 14:13
To Make the First Decision	2017-04-21 10:04
Return for Revision	2017-04-27 11:43
Revised	2017-05-12 18:48
Second Decision	2017-07-06 07:14
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2017-07-12 06:01
Articles in Press	2017-07-12 06:01
Publication Fee Transferred	2017-07-26 11:07
Edit the Manuscript by Language Editor
Typeset the Manuscript	2017-08-15 02:28
Publish the Manuscript Online	2017-08-28 06:54

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Randomized Controlled Trial
Article Title	New botanical drug, HL tablet, reduces hepatic fat as measured by magnetic resonance spectroscopy in patients with nonalcoholic fatty liver disease: A placebo-controlled, randomized, phase Ⅱ trial
Manuscript Source	Unsolicited Manuscript
All Author List	Jae Yoon Jeong, Joo Hyun Sohn, Yang Hyun Baek, Yong Kyun Cho, Yongsoo Kim and Hyeonjin Kim
Funding Agency and Grant Number
Corresponding Author	Joo Hyun Sohn, MD, PhD, Professor, Department of Internal Medicine, Hanyang University Guri Hospital, Hanyang University College of Medicine, 153 Gyeongchun-ro, Guri 11923, South Korea. sonjh@hanyang.ac.kr
Key Words	Botanical drug; Nonalcoholic fatty liver disease; Magnetic resonance spectroscopy; Randomized controlled trial; Magnolia officinali
Core Tip	The prevalence of nonalcoholic fatty liver disease (NAFLD) is growing gradually with the increase in population age and obesity, while effective and safe drugs for NAFLD are not yet available. HL tablet, a new botanic drug extracted from magnolia officinalis, is effective in reducing hepatic fat content without any negative lipid profiles, body mass index changes and adverse effects.
Publish Date	2017-08-28 06:54
Citation	Jeong JY, Sohn JH, Baek YH, Cho YK, Kim Y, Kim H. New botanical drug, HL tablet, reduces hepatic fat as measured by magnetic resonance spectroscopy in patients with nonalcoholic fatty liver disease: A placebo-controlled, randomized, phase Ⅱ trial. World J Gastroenterol 2017; 23(32): 5977-5985
URL	http://www.wjgnet.com/1007-9327/full/v23/i32/5977.htm
DOI	http://dx.doi.org/10.3748/wjg.v23.i32.5977

Full Article (PDF)	WJG-23-5977.pdf
Full Article (Word)	WJG-23-5977.doc
Manuscript File	33335-Review.docx
Answering Reviewers	33335-Answering reviewers.pdf
Audio Core Tip	33335-Audio core tip.WAV
Conflict-of-Interest Disclosure Form	33335-Conflict-of-interest statement.pdf
Copyright License Agreement	33335-Copyright assignment.pdf
Signed Informed Consent Form(s) or Document(s)	33335-Informed consent statement.pdf
Institutional Review Board Approval Form or Document	33335-Institutional review board statement.pdf
Non-Native Speakers of English Editing Certificate	33335-Language certificate.pdf
Supplementary Material	33335-Supplementary material.pdf
Peer-review Report	33335-Peer-review(s).pdf
Scientific Misconduct Check	33335-Scientific misconduct check.pdf
Scientific Editor Work List	33335-Scientific editor work list.pdf